Protalix BioTherapeutics PLX
NYSE PLX
$2.57 -0.07 (-2.65%)
As of: Oct 21, 2026 · 3:59 PM EDT

Protalix BioTherapeutics (PLX) Other Non-Current Assets (2010 - 2014)

Updated

Protalix BioTherapeutics (PLX) recorded Other Non-Current Assets of $135,000 in Q1 2014, down 4.3% from the prior quarter.

Analysis

Protalix BioTherapeutics (PLX) Other Non-Current Assets (2010 - 2014) Analysis & Trends

At the end of FY2013, Protalix BioTherapeutics reported Other Non-Current Assets of $141,000.

  • Annual Other Non-Current Assets has a three-year compound annual growth rate of -46.9% (FY2010 to FY2013).
  • Across earlier years, Other Non-Current Assets came in at $942,000 in FY2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 7.48 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 14.27 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 10.73 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 19.60 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 5.93 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 12.98 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 4.75 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 9.94 Bn
10 Protalix BioTherapeutics 207.16 Mn 55.78 Mn 12.13 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 135,000.00
Dec 31, 2013 141,000.00
Sep 30, 2013 149,000.00
Sep 30, 2011 2.04 Mn
Jun 30, 2011 1.75 Mn
Dec 31, 2010 942,000.00
API Access

Protalix BioTherapeutics Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=PLX&period=max&api_key=YOUR_API_KEY